Search

everythinglearnresearchcommunity

for

Search:↓

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Biotrinine® may be an effective treatment for chronic hair loss.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Targeting the Smoothened receptor shows promise for treating certain cancers.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

Isoquercitrin helps hair grow by activating certain cell processes.

Erlotinib may cause scarring hair loss.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

HDAC inhibitors like Vorinostat and Entinostat may encourage hair regrowth and could be new treatments for hair loss conditions.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Upadacitinib effectively treats psoriasis and lichen planus together.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Minoxidil improves hair loss in breast cancer patients on CDK4/6-inhibitor therapy.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

New therapies are being developed that target integrin pathways to treat various diseases.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.